Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Multiple Myeloma × ulocuplumab × Clear all

Status

No longer available 1 Completed 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

elotuzumab 4 Lenalidomide 3 Dexamethasone 3 Bortezomib 3 Panobinostat 2 ulocuplumab 1 talquetamab 1 selinexor 1 pomalidomide 1 plerixafor 1 fludarabine phosphate 1 carfilzomib 1 Whole-Body Irradiation 1 Tacrolimus 1 Prednisone 1 Mycophenolic Acid 1 Melphalan 1 Cytarabine 1 Cord Blood Stem Cell Transplantation 1 Calcium Dobesilate 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02666209 2017-08-28

Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma

Dana-Farber Cancer Institute

No longer available

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡